"GenomicTree, Inc. - Product Pipeline Analysis, 2013 Update" Is Now Available at Fast Market Research
GenomicTree, Inc. (GenomicTree) is a molecular diagnostic company. It develops and commercializes diagnostic products for cancer screening and prognosis of patient outcomes. The company discovers and identifies methylation biomarkers using its Methyl DNA Scan platform technologies. It has also developed identification system ofmethylation of associated genes inactivated in cancer. GenomicTree's product pipeline comprises, exfoliated cell-based cancer screening tests, applicable to cervical, lung, bladder, colon, stomach, breast and thyroid cancers; prognosis tests for cervical cancer progression and colon cancer recurrence; and...
View full press release